PDE10A inhibition may also ameliorate HD-specific deficits in cAMP signaling, as proposed to occur based on findings in HD models [12] and as evidenced by decreased levels of cAMP in cerebrospinal fluid sampled from HD patients [44]. The gene discussed is PDE10A; the disease is Huntington disease.